Latest Headlines
-
Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement With Futura Surgicare Pvt Ltd.
2/21/2024
Novo Integrated Sciences, Inc., and Clinical Consultants International, LLC (“CCI”), a Novo wholly-owned subsidiary, today announced the signing of a Consulting Services Agreement (the “Agreement”), with Futura Surgicare Pvt Ltd (“Futura”), an India-based leading manufacturer of wound closure and surgical products that are marketed and distributed in over 70 countries worldwide under the trade name “Dolphin Sutures”.
-
Aptar Digital Health Announces Acquisition Of Healint To Reinforce Digital Health Portfolio And Drive Future Growth
2/21/2024
Aptar Digital Health, a global leader in digital health solutions (Software as a Medical Device (SaMD) and digital Patient Support Programs), connected devices and disease management, today announced that it has acquired Healint, a digital health company recognized for their virtual clinical studies, real-world evidence and patient registries platform, as well as the Migraine Buddy and Clarrio mobile apps, which support patients suffering from neurological and immunological conditions.
-
Community Health Systems Completes Data Migration And Implements New Generative AI Innovations With Google Cloud
1/31/2024
Community Health Systems, Inc. (NYSE: CYH), one of the nation's leading healthcare companies, and Google Cloud today announced that CHS has completed migration to a Fast Healthcare Interoperability Resources 1 (FHIR)-based clinical data platform and is now implementing new generative AI (gen AI) innovations using Google Cloud technologies.
-
Rauland Announces General Availability Of Enterprise Converge To Revolutionize Hospital Workflows And Efficiency
1/30/2024
Hospitals and healthcare organizations are now able to benefit from Converge, the latest innovation from Rauland®, a global leader in healthcare clinical communications and workflow solutions.
-
A.D.A.M. And The Icahn School Of Medicine At Mount Sinai Announce Collaboration To Advance Bone Implant Technology And Healthcare Innovation
1/26/2024
Advanced Development of Additive Manufacturing (A.D.A.M.), a provider of 3D printing systems for customized bone implants, and the Icahn School of Medicine at Mount Sinai, in New York, NY, a renowned educational and health institution, have established a collaboration, which aims to enhance healthcare by innovating in bone implant delivery and soft tissue medical device development.
-
In The War On Cancer, Tampa General Hospital Cancer Institute Employs AI In Its Newly Established Center For Precision Radiosurgery
1/25/2024
Going under the knife is taking on a new and more promising meaning at Tampa General Hospital (TGH) Cancer Institute, where doctors are using a sophisticated AI-driven tool to treat cancer.
-
SS Innovations Partners With India’s Leading Medical Equipment Supplier, Medikabazaar
1/25/2024
SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced it has entered into a partnership with India’s leading medical equipment supplier, Medikabazaar, to facilitate sales of its flagship SSi Mantra Surgical Robotic System to hospitals and medical facilities across India.
-
Kyndryl Helps Norway’s DIPS Improve Medical Services
1/25/2024
Kyndryl, the world’s largest IT infrastructure services provider, today announced that it has implemented a robust Managed Kubernetes platform for DIPS AS, the leading supplier of eHealth systems to Norwegian hospitals.
-
ClearSky Health To Build Medical Rehabilitation Hospital In Rockwall County, Texas
1/23/2024
ClearSky Health, a premier rehabilitative healthcare provider, has announced plans to build a new 36-bed medical rehabilitation hospital in Rockwall County, Texas.
-
Children's Hospital Of Philadelphia Performs First In U.S. Gene Therapy Procedure To Treat Genetic Hearing Loss
1/23/2024
Children's Hospital of Philadelphia (CHOP) is proud to announce the initial results of an experimental gene therapy treatment of a patient with hereditary hearing loss in the United States.